Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015610
Filing Date
2021-11-12
Accepted
2021-11-12 06:26:13
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cann-20210930x10q.htm   iXBRL 10-Q 2140342
2 EX-31.1 cann-20210930xex31d1.htm EX-31.1 11425
3 EX-31.2 cann-20210930xex31d2.htm EX-31.2 11376
4 EX-32.1 cann-20210930xex32d1.htm EX-32.1 10041
  Complete submission text file 0001558370-21-015610.txt   8687037

Data Files

Seq Description Document Type Size
5 EX-101.SCH cann-20210930.xsd EX-101.SCH 69312
6 EX-101.CAL cann-20210930_cal.xml EX-101.CAL 70632
7 EX-101.DEF cann-20210930_def.xml EX-101.DEF 286597
8 EX-101.LAB cann-20210930_lab.xml EX-101.LAB 502663
9 EX-101.PRE cann-20210930_pre.xml EX-101.PRE 456102
10 EXTRACTED XBRL INSTANCE DOCUMENT cann-20210930x10q_htm.xml XML 1536512
Mailing Address 6565 EAST EVANS AVENUE DENVER CO 80224
Business Address 6565 EAST EVANS AVENUE DENVER CO 80224 303-759-1300
GENERAL CANNABIS CORP (Filer) CIK: 0001477009 (see all company filings)

EIN.: 208096131 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54457 | Film No.: 211399211
SIC: 2833 Medicinal Chemicals & Botanical Products